European Respiratory Society (ERS) International Congress 2020

Vienna 05 September 2020 - 09 September 2020

Amoxicillin-clavulanate regimen for PBB: 4 weeks no better than 2 weeks

28 Sep 2020 by

A 4-week course of amoxicillin-clavulanate in children with protracted bacterial bronchitis (PBB) does not improve cough resolution rates compared with a 2-week course, according to a study from Australia. However, the longer course may significantly extend time to first cough exacerbation.

Amoxicillin-clavulanate regimen for PBB: 4 weeks no better than 2 weeks

28 Sep 2020

Dupilumab cuts exacerbation rates in patients with asthma regardless of lung function

28 Sep 2020 by

Patients with moderate-to-severe asthma had significant reductions in annualized severe asthma exacerbation rate with the monoclonal antibody dupilumab, regardless of lung function, according to a post hoc analysis of LIBERTY ASTHMA QUEST* presented at ERS 2020.

Dupilumab cuts exacerbation rates in patients with asthma regardless of lung function

28 Sep 2020

Brensocatib tackles exacerbations in bronchiectasis

22 Sep 2020 by

Treatment with the DPP 1* inhibitor brensocatib prolonged time to exacerbation and reduced exacerbation rates in patients with non-cystic fibrosis bronchiectasis, according to the phase II WILLOW** study presented at ERS 2020.

Brensocatib tackles exacerbations in bronchiectasis

22 Sep 2020

Masitinib demonstrates potential for severe asthma

22 Sep 2020 by

The first-in-class oral tyrosine kinase inhibitor (TKI) masitinib demonstrated a positive benefit-risk profile over a sustained period in patients with severe persistent asthma regardless of baseline eosinophil level, with the greatest benefit seen among those with the highest oral corticosteroid (OCS) dependency, according to data presented at ERS 2020.

Masitinib demonstrates potential for severe asthma

22 Sep 2020

How to control asthma well: Experts’ perspectives

21 Sep 2020 by

Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.

How to control asthma well: Experts’ perspectives

21 Sep 2020

Vitamin D, bariatric surgery increase corticosteroid sensitivity in obese asthmatic patients

21 Sep 2020 by

Vitamin D therapy and bariatric surgery in obese asthmatic patients both improve peripheral blood mononuclear cells (PBMC) sensitivity to the in vitro corticosteroid (CS) treatment, results of a Spain study have shown.

Vitamin D, bariatric surgery increase corticosteroid sensitivity in obese asthmatic patients

21 Sep 2020

City vs province: How does asthma differ with address?

21 Sep 2020 by

Asthma manifests differently between patients from urban and rural areas, likely due in part to differing environments, according to a recent study presented at the virtual International Congress 2020 of the European Respiratory Society (ERS 2020).

City vs province: How does asthma differ with address?

21 Sep 2020

Genotyping helps optimize asthma treatment in children

21 Sep 2020 by

In children with asthma, genotype testing identifies a specific genetic alteration associated with poor response to long-acting β2 agonist (LABA), as shown in the PACT trial. This information proves useful in prescribing appropriate medications and improving asthma control.

Genotyping helps optimize asthma treatment in children

21 Sep 2020

Night-time cough a useful digital biomarker for asthma control

19 Sep 2020 by

Frequent coughing at night, measured using a smartphone app, appears to be a reliable indicator of worsening asthma, as reported in a study presented at this year’s European Respiratory Society (ERS) virtual meeting.

Night-time cough a useful digital biomarker for asthma control

19 Sep 2020

Gefapixant cuts frequency of chronic coughs in 2 large studies

18 Sep 2020 by

Gefapixant, a first-in-class non-narcotic, oral P2X3 receptor antagonist, significantly reduces cough frequency in patients with refractory or unexplained chronic cough, according to two COUGH* studies presented at ERS 2020.

Gefapixant cuts frequency of chronic coughs in 2 large studies

18 Sep 2020